Simplex Trading
DNA icon

Simplex Trading’s Ginkgo Bioworks DNA Stock Holding History

Simplex Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$500K Buy
39,000
+22,500
+136% +$183K ﹤0.01% 3569
2026
Q2 		$164K Buy
16,500
+12,500
+313% +$105K ﹤0.01% 4963
2026
Q1 		$24.5K Buy
+4,000
New +$33.3K ﹤0.01% 6597
2025
Q4 		– Sell
-610,000
Closed -$8.89M – 8877
2025
Q3 		$8.89M Sell
610,000
-207,800
-25% -$2.49M ﹤0.01% 1045
2025
Q2 		$9.2M Buy
817,800
+242,300
+42% +$1.88M 0.01% 943
2025
Q1 		$3.28M Sell
575,500
-356,500
-38% -$3.63M ﹤0.01% 1591
2024
Q4 		$9.15M Sell
932,000
-193,600
-17% -$1.66M 0.01% 1085
2024
Q3 		$9.17M Buy
1,125,600
+1,104,112
+5,138% +$11.1M 0.01% 1088
2024
Q2 		$287K Buy
21,488
+10,243
+91% +$306K ﹤0.01% 4290
2024
Q1 		$521K Sell
11,245
-1,828
-14% -$94.6K ﹤0.01% 3821
2023
Q4 		$868K Buy
13,073
+2,058
+19% +$126K ﹤0.01% 3139
2023
Q3 		$797K Buy
11,015
+1,612
+17% +$129K ﹤0.01% 2899
2023
Q2 		$699K Sell
9,403
-1,107
-11% -$65.5K ﹤0.01% 2959
2023
Q1 		$559K Sell
10,510
-6,515
-38% -$413K ﹤0.01% 3147
2022
Q4 		$1.15M Sell
17,025
-5,340
-24% -$491K ﹤0.01% 2334
2022
Q3 		$2.79M Buy
22,365
+18,397
+464% +$2.19M ﹤0.01% 1678
2022
Q2 		$377K Sell
3,968
-1,992
-33% -$243K ﹤0.01% 3809
2022
Q1 		$960K Sell
5,960
-1,028
-15% -$200K ﹤0.01% 2969
2021
Q4 		$2.32M Buy
+6,988
New +$3.32M ﹤0.01% 1888

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Simplex Trading's DNA Position: Q3 2026 in Review

Simplex Trading increased its Ginkgo Bioworks (DNA) stake by 369% in Q3 2026, buying an estimated $540K and bringing the position to 84,325 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

Simplex Trading first reported a position in DNA in Q1 2022 and has held it in 16 quarters since. 65 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Simplex Trading held 84,325 shares of Ginkgo Bioworks worth $1.08M as of Q3 2026.
  • Simplex Trading bought 66,330 Ginkgo Bioworks shares in Q3 2026, an estimated $540K.
  • Ginkgo Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2641 holding.
  • Simplex Trading first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 16 quarters since.
  • 65 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.